JOURNAL OF HEPATOLOGY, cilt.68, sa.6, ss.1129-1136, 2018 (SCI-Expanded)
Background & Aims: The effects of long-term antiviral therapy on survival have not been adequately assessed in chronic hepatitis B (CHB). In this 10-centre, ongoing cohort study, we evaluated the probability of survival and factors affecting survival in Caucasian CHB patients who received long-term entecavir/tenofovir therapy.